Drug Shortage Report for TARO-PEMETREXED

Last updated on 2024-01-05 History
Report ID 181893
Drug Identification Number 02429209
Brand name TARO-PEMETREXED
Common or Proper name PEMETREXED
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) PEMETREXED
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20ML
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-01-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-01-05 French Compare
v15 2024-01-05 English Compare
v14 2023-08-16 French Compare
v13 2023-08-16 English Compare
v12 2023-07-18 French Compare
v11 2023-07-18 English Compare
v10 2023-04-10 French Compare
v9 2023-04-10 English Compare
v8 2023-03-24 French Compare
v7 2023-03-24 English Compare
v6 2023-03-10 French Compare
v5 2023-03-10 English Compare
v4 2023-02-01 French Compare
v3 2023-02-01 English Compare
v2 2023-01-19 French Compare
v1 2023-01-19 English Compare

Showing 1 to 16 of 16